Takeda · 1 week ago
Associate Director, Statistics (Hybrid)
Takeda is a global, values-based, R&D-driven, top 10 biopharmaceutical leader committed to discover and deliver life-transforming treatments. The Associate Director, Statistics role involves leading delivery strategies for clinical assets, facilitating collaboration across functions, and contributing to the design and analysis of clinical trials.
BiotechnologyHealth CareManufacturingMedicalPharmaceutical
Responsibilities
Lead delivery for one or more assets at GPT level or specialty area in clinical
Facilitate execution and delivery collaboration cross functionally in Global Project Teams (GPTs), generally within DQS and R&D, and with external vendors
Enable the consistent execution of the SQS and DQS seamless and predictable delivery mission
Lead and be accountable for asset level delivery strategies being implemented with effective risk identification and mitigation
Create an internal cross functional and external with vendors sphere of influence in predictable delivery
Identify opportunity for continuous improvement in delivery approaches and leverages fit-for-purpose mitigations by leveraging them
Asset-level GPT strategy and delivery
Broadly DQS functions
Parts R&D functions
Qualification
Required
PHD with ~ 5 years experience
MS with ~ 8+ years experience
Advanced knowledge of clinical study designs, analysis methodology and data interpretation
Advanced knowledge of pharmaceutical industry, overall drug development process with expertise in the cross-functional interfaces with the Statistics function
Advanced knowledge of FDA and ICH regulations and industry standards applicable to the design, analysis of clinical trials and regulatory submissions
Strong statistical programming skills
Excellent oral and written communications skills
Specialized statistical expertise in multiple therapeutic areas or development phases
Strong inter-personal and people management skills
Strong project management skills
Strong collaborative skills and ability to work with a cross-functional team
Subject matter expertise in several quantitative and statistical areas and establishes oneself as a go-to colleague on a few topics
Scientific understanding of drug R&D to inform methodological input with product team or in a platform
Strong communication skills and ability to translate effectively across functional lines
Ability to Identify and research new innovative approaches and leverage fit-for-purpose methods in to programs that he/she is involved in
Lead one or more assets at GPT level or specialty area in preclinical, clinical, translational
Facilitate collaboration cross functionally in GPTs and generally within DQS and R&D
Enable the tactical execution of the SQS and DQS vision and mission
Lead and be accountable for asset level strategies being implemented
Demonstrate mentorship, matrix or direct management of small team of SQS colleagues
Create an internal and external sphere of influence in area of expertise
Benefits
U.S. based employees may be eligible for short-term and/ or long-term incentives.
U.S. based employees may be eligible to participate in medical, dental, vision insurance, a 401(k) plan and company match, short-term and long-term disability coverage, basic life insurance, a tuition reimbursement program, paid volunteer time off, company holidays, and well-being benefits, among others.
U.S. based employees are also eligible to receive, per calendar year, up to 80 hours of sick time, and new hires are eligible to accrue up to 120 hours of paid vacation.
Company
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
H1B Sponsorship
Takeda has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (39)
2023 (38)
2022 (34)
2021 (44)
2020 (18)
Funding
Current Stage
Public CompanyTotal Funding
$2.46B2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-11
Company data provided by crunchbase